NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDCladribine
(Tablets) 		Malignant disease and immunosuppression, Antimetabolites, 08.01.03
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Cladribine Cladribine Immune System, Antineoplastic Drugs, Antimetabolites
Immune System Disorders And Transplantation, Multiple Sclerosis
Cladribine Cladribine Malignant Disease, Antineoplastic Drugs, Antimetabolites
Cytotoxic Responsive Malignancy
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
Cladribine (Mavenclad): new advice to minimise risk of serious liver injury DSU March 2022
MHRA Drug Safety Update (Dec 2017): Cladribine (Litak, Leustat) for leukaemia: reports of progressive multifocal encephalopathy (PML); stop treatment if PML suspected
NICE TA 616 Cladribine for treating relapsing–remitting multiple sclerosis
NICE TA1053: Cladribine for treating active relapsing forms of multiple sclerosis